clopidogrel has been researched along with Stevens-Johnson Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callaghan, JT; Mendes, M; Meyer, LJ; Pratt, VM; Przygodzki, RM; Scheuner, MT; Schichman, SA; Stone, A; Vassy, JL; Wang-Rodriguez, J | 1 |
| Báez-Ferrer, N; Domínguez-Rodríguez, A; Grande-Flecha, AS | 1 |
| Chowbay, B; Sutiman, N | 1 |
| Hou, XM; Wu, WY | 1 |
4 other study(ies) available for clopidogrel and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee.
Topics: Clopidogrel; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Genotype; Glucosephosphate Dehydrogenase; HLA-B15 Antigen; Humans; Pharmacogenetics; Pharmacogenomic Testing; Stevens-Johnson Syndrome; United States; United States Department of Veterans Affairs; Veterans; Veterans Health | 2019 |
Stevens-Johnson Syndrome and Treatment With Clopidogrel.
Topics: Aged; Clopidogrel; Humans; Male; Platelet Aggregation Inhibitors; Skin; Stevens-Johnson Syndrome | 2019 |
Pharmacogenetics and its relevance to clinical practice.
Topics: Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Asian People; Camptothecin; Carbamazepine; Clopidogrel; Cytochrome P-450 CYP2C19; Glucuronosyltransferase; HLA-A Antigens; HLA-B Antigens; Humans; Irinotecan; Platelet Aggregation Inhibitors; Stevens-Johnson Syndrome; Ticlopidine; Topoisomerase I Inhibitors | 2013 |
Toxic epidermal necrolysis after percutaneous coronary intervention: which drug is the culprit?
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Humans; Male; Middle Aged; Stevens-Johnson Syndrome; Ticlopidine | 2011 |